Microrna-206 Induces G1 Arrest in Melanoma by Inhibition of Cdk4 and Cyclin D
Robert W. Georgantas,Katie Streicher,Xiaobing Luo,Lydia Greenlees,Wei Zhu,Zheng Liu,Philip Brohawn,Christopher Morehouse,Brandon W. Higgs,Laura Richman,Bahija Jallal,Yihong Yao,Koustubh Ranade
DOI: https://doi.org/10.1111/pcmr.12200
2013-01-01
Pigment Cell & Melanoma Research
Abstract:SummaryExpression profiling of microRNAs in melanoma lesional skin biopsies compared with normal donor skin biopsies, as well as melanoma cell lines compared with normal melanocytes, revealed that hsa‐miR‐206 was down‐regulated in melanoma (−75.4‐fold, P = 1.7 × 10−4). MiR‐206 has been implicated in a large number of cancers, including breast, lung, colorectal, ovarian, and prostate cancers; however, its role in tumor development remains largely unknown, its biologic function is poorly characterized, and its targets affecting cancer cells are largely unknown. MiR‐206 reduced growth and migration/invasion of multiple melanoma cell lines. Bioinformatics identified cell cycle genes CDK2, CDK4, Cyclin C, and Cyclin D1 as strong candidate targets. Western blots and 3′UTR reporter gene assays revealed that miR‐206 inhibited translation of CDK4, Cyclin D1, and Cyclin C. Additionally, hsa‐miR‐206 transfection induced G1 arrest in multiple melanoma cell lines. These observations support hsa‐miR‐206 as a tumor suppressor in melanoma and identify Cyclin C, Cyclin D1, and CDK4 as miR‐206 targets.